International Cholangiocarcinoma
Research Network
The ICRN is a global collaboration of research groups from renowned institutions who are working in concert to improve knowledge about cholangiocarcinoma etiology, prevention, early detection, treatment, and prognosis. The network is comprised of highly talented individuals from a spectrum of disciplines, perspectives, and research methods who share a passion to make significant scientific advances to improve outcomes for patients with cholangiocarcinoma.
Our core
mission:
to rapidly translate scientific discoveries into practice for cholangiocarcinoma patients through a collaborative, highly translational international research network.
Our Executive Committee Leadership
Mitesh Borad, MD
Mayo Clinic
Nilo Azad, MD
John Hopkins University
Milind Javle, MD
MD Anderson Cancer Center
Stacie Lindsey
Cholangiocarcinoma Foundation
Reham Abdel-Wahab, MD, PhD
Cholangiocarcinoma Foundation
Our Executive Committee Members
Ghassan Abou-Alfa, MD
Memorial Sloan Kettering Cancer Center
Laura Goff, MD
Vanderbilt University
Lipika Goyal, MD
MGH/Harvard
Eugene Koay, MD, PhD
MD Anderson Cancer Center
Amit Mahipal, MBBS
Mayo Clinic
Shishir Maithel, MD
Winship Cancer Institute
Lewis Roberts, MB, ChB, PhD
Mayo Clinic
Flavio Rocha, MD
Oregon Health & Science University
Sameek Roychowdhury, MD, PhD
The Ohio State University
Rachna Shroff, MD
University of Arizona Cancer Center
International
John Bridgewater, PhD
University College London Hospital
United Kingdom
Suebpong Tanasanvimon, MD
Bumrungrad International Hospital, Thailand
Cholangiocarcinoma Foundation
Melinda Bachini
Cholangiocarcinoma Foundation
Director of Patient Services
The International Cholangiocarcinoma Research Network (ICRN) is a program of the Cholangiocarcinoma Foundation.